Research programme: inflammatory diseases - Digital Gene Technologies
Latest Information Update: 14 May 2008
At a glance
- Originator Digital Gene Technologies
- Developer Amgen; Digital Gene Technologies
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammatory bowel diseases
Most Recent Events
- 14 May 2008 Discontinued - Preclinical for Inflammatory bowel disease in USA (unspecified route)
- 12 Aug 2002 Preclinical trials in Inflammatory bowel disease in USA (unspecified route)